HAMILTON, Canada, July 9, 2010 /PRNewswire/ -- An
ultra-low-molecular-weight heparin called semuloparin has been found to
reduce the incidence of venous thromboembolism in orthopedic surgery patients
in a large clinical program being led by a steering committee chaired by
McMaster University pro